Mackenzie Financial’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-111,310
| Closed | -$421K | – | 1669 |
|
|
2024
Q4 | $421K | Buy |
111,310
+78,070
| +235% | +$295K | ﹤0.01% | 1246 |
|
|
2024
Q3 | $108K | Sell |
33,240
-24,683
| -43% | -$80K | ﹤0.01% | 1473 |
|
|
2024
Q2 | $110K | Sell |
57,923
-14,649
| -20% | -$27.8K | ﹤0.01% | 1423 |
|
|
2024
Q1 | $206K | Buy |
+72,572
| New | +$206K | ﹤0.01% | 1334 |
|